23
Participants
Start Date
June 30, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
PF-00446687
Single 200mg dose
Placebo
Pfizer Investigational Site, Kobenhavn OE
Pfizer Investigational Site, Oslo
Pfizer Investigational Site, Danderyd
Lead Sponsor
Pfizer
INDUSTRY